-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VWTZmgKI0+pL+CenwCnowLJssuPOXT/D/1yGIY7bKve6dpF6/n8xvPGcUod+kiZ0 fwSRgX32ZojXp1MB/XJGmg== 0000950129-04-007967.txt : 20041022 0000950129-04-007967.hdr.sgml : 20041022 20041022162228 ACCESSION NUMBER: 0000950129-04-007967 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041022 ITEM INFORMATION: Other Events FILED AS OF DATE: 20041022 DATE AS OF CHANGE: 20041022 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STAAR SURGICAL CO CENTRAL INDEX KEY: 0000718937 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 953797439 STATE OF INCORPORATION: DE FISCAL YEAR END: 0101 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-11634 FILM NUMBER: 041092128 BUSINESS ADDRESS: STREET 1: 1911 WALKER AVE CITY: MONROVIA STATE: CA ZIP: 91016 BUSINESS PHONE: 6263037902 MAIL ADDRESS: STREET 1: 1911 WALKER AVE CITY: MONROVIA STATE: CA ZIP: 91016 FORMER COMPANY: FORMER CONFORMED NAME: STAAR SURGICAL COMPANY DATE OF NAME CHANGE: 19920703 8-K 1 a02604e8vk.htm STAAR SURGICAL COMPANY - OCTOBER 22, 2004 e8vk
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 22, 2004

STAAR SURGICAL COMPANY

(Exact name of registrant as specified in its charter)
         
Delaware
(State or other jurisdiction
of incorporation or organization) 		  0-11634
(Commission File Number) 		  95-3797439
(I.R.S. Employer Identification No.)
     
1911 Walker Avenue, Monrovia, California
(Address of principal executive offices) 		  91016
(Zip Code)

(626) 303-7902
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

- 1 -

TABLE OF CONTENTS

Item 8.01. Other Events.
SIGNATURES

Table of Contents

Item 8.01. Other Events.

     As previously announced on September 29, 2004, the United States Food and Drug Administration (the “FDA”) completed the inspection of the Company’s Monrovia facility on September 23, 2004 and issued a form “FDA 483 Inspectional Observations” (the “FDA 483”). The Company intends to respond to the FDA 483 on November 4, 2004.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
         
  STAAR SURGICAL COMPANY
 		  
Date: October 22, 2004  By:   /s/ John Bily    
    John Bily,   
    Chief Financial Officer   
 

- 2 -

-----END PRIVACY-ENHANCED MESSAGE-----